Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Antibiotic Resistance Market Report 2025

Antibiotic Resistance Global Market Report 2025 – By Drug Class (Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes), By Pathogen (Staphylococcus aureus, Staphylococcus pneumonia, Neisseria gonorrhoeae, Enterococcus Faecium, Escherichia coli, Klebsiella pneumonia, Shigella, Clostridium difficile, Other pathogens), By Disease Type (Urinary tract infection, Intra-abdominal infection, Blood stream infections, Clostridium difficile infections, Other Disease Types), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions), By End Users (Hospitals, Homecare, Specialty clinics, Other End-users) – Market Size, Trends, And Global Forecast 2025-2034

Antibiotic Resistance Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Antibiotic Resistance Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Antibiotic Resistance Market Definition

Antimicrobial resistance is a condition that occurs when microorganisms such as bacteria and fungi gain the capacity to resist medications that are meant to kill them. Resistance to infections is challenging to treat, leading to the death of an infected individual in the worst cases.

The main antibiotic-resistance drug classes are beta-lactam antibiotics, cephalosporins, quinolone antibiotics, macrolide antibiotics, tetracyclines, oxazolidinones, and others. Beta-lactam antibiotics are antibiotics containing a beta-lactam ring in their chemical structure that is used to prevent bacterial cell wall construction by covalently attaching to key penicillin-binding proteins (PBPs) that inhibit the growth of organisms. The various pathogens include staphylococcus aureus, staphylococcus pneumonia, Neisseria gonorrhoeae, enterococcus faecium, escherichia coli, klebsiella pneumonia, shigella, Clostridium difficile, and others that are used during diseases such as urinary tract infection, intra-abdominal infection, bloodstream infections, clostridium difficile infections, and others. The various mechanisms include protein synthesis inhibitors, cell wall synthesis inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, and others that are used by different end users such as hospitals, homecare, specialty clinics, and others.

Antibiotic Resistance Market Segmentation

The antibiotic resistance market covered in this report is segmented –

1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes

2) By Pathogen: Staphylococcus Aureus, Staphylococcus Pneumonia, Neisseria Gonorrhoeae, Enterococcus Faecium, Escherichia Coli, Klebsiella Pneumonia, Shigella, Clostridium Difficile, Other Pathogens

3) By Disease Type: Urinary Tract Infection, Intra-Abdominal Infection, Blood Stream infections, Clostridium Difficile Infections, Other Disease Types

4) By Mechanism Of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions

5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End-users

Subsegments:

1) By Beta Lactam Antibiotics: Penicillins, Cephalosporins, Carbapenems, Monobactams

2) By Cephalosporins: First-generation, Second-generation, Third-generation, Fourth-generation

3) By Quinolones Antibiotics: Fluoroquinolones, Other Quinolones

4) By Macrolide Antibiotics: Erythromycin, Azithromycin, Clarithromycin

5) By Tetracyclines: Doxycycline, Minocycline, Tetracycline

6) By Oxazolidinones: Linezolid, Tedizolid

7) By Other Drug Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins

Antibiotic Resistance Market Size and growth rate 2025 to 2029: Graph

Antibiotic Resistance Market Size 2025 And Growth Rate

The antibiotic resistance market size has grown strongly in recent years. It will grow from $12.21 billion in 2024 to $12.89 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to lack of new antibiotics, misuse and overuse of antimicrobials in humans, animals, and plants, highly contaminated waste effluents, low vaccination rates, lack of diagnostic tools

Antibiotic Resistance Market Growth Forecast

The antibiotic resistance market size is expected to see strong growth in the next few years. It will grow to $16.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to incomplete treatment courses, globalization and travel, poor infection prevention and control, self-medication, cross-species transmission, high population density. Major trends in the forecast period include technological innovations in drug delivery, global collaboration for surveillance, expanding role of artificial intelligence, surge in novel therapies.

Book your 30 minutes free consultation with our research experts

Contact Us

Antibiotic Resistance Market Driver: The Impact Of Rising Drug-Resistant Infections On The Antibiotic Resistance Market

The prevalence of drug-resistant infections is expected to propel the growth of the antibiotic-resistance market going forward. Drug-resistant infections are diseases caused by resistant bacteria, resulting in an infection that is far more difficult or impossible to cure. Antimicrobial resistance drugs help treat various drug-resistant infections with improved antibiotic treatment outcomes concerning both target and nontarget pathogens, dependent on the details of resistance mechanisms and microbiome community interaction structure. For instance, in November 2023, according to the report published by the UK Health Security Agency, a UK-based government agency, approximately 58,224 individuals in England were estimated to have had an antibiotic-resistant infection in 2022, marking a 4% increase from the 55,792 cases reported in 2021. Therefore, the prevalence of drug resistance infection is driving the antibiotic resistance market.

Antibiotic Resistance Market Driver: The Influence Of Increasing Global Healthcare Spending On The Expansion Of The Antibiotic Resistance Market

The growing healthcare expenditure is expected to boost the growth of the antibiotic resistance market going forward. Healthcare expenditure refers to the total amount of financial resources spent by individuals, communities, or governments on healthcare-related goods and services within a specified period. Healthcare spending foster antibiotic resistance market growth, facilitating heightened research, development, and adoption of innovative treatments, thereby addressing challenges posed by antibiotic-resistant infections and driving market expansion. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, the projected growth indicates that, on average, national health spending is expected to increase by 5.1% annually between 2021 and 2030, reaching a total of nearly $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the growing healthcare expenditure is driving the growth of the antibiotic resistance market.

Global Antibiotic Resistance Market Major Players

Major companies operating in the antibiotic resistance market include Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Merck and Co. Inc., Bristol-Myers Squibb, Sanofi S.A., Thermo Fisher Scientific Inc, AstraZeneca, GlaxoSmithKline Plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Astellas Pharma, Daiichi Sankyo, Chugai Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Bio-Rad Laboratories Inc, Eppendorf Corporation, Takara Bio Inc, Wockhardt Ltd., Paratek Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Theravance Biopharma Inc., Nabriva Therapeutics Plc, Seres Therapeutics Inc, Armata Pharmaceuticals Inc.

Global Antibiotic Resistance Market Trend: Product Innovations In The Antibiotic Resistance Market

Product innovations are the key trend gaining popularity in the antibiotic resistance market. Major companies operating in the antibiotic resistance market are focused on developing innovative products to strengthen their position in the market. For instance, in January 2023, Alkem Laboratories Limited, an India-based pharmaceutical company, introduced Zidavi, a novel antibiotic for multi-drug resistant (MDR) infections, to ensure availability, affordability, and accessibility while saving the lives of critically ill patients. Zidavi is a unique combination of ceftazidime and avibactam that can treat infections caused by multi-drug resistant (MDR) gram-negative pathogens. It is available for infusion in sterile powdered concentrate for reconstitution, comprising ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam in each single-dose vial. Also, it offers an effective alternative to treat hospital-acquired pneumonia (HAP) and severe intra-abdominal infections (IAIs) caused by meropenem and colistin.

Global Antibiotic Resistance Market Trend: Advancements In The Antibiotic-Resistance Market Fueled By Strategic Collaborations

Major companies operating in the antibiotic-resistance market are adopting a strategic partnership approach to develop the next generation of antimicrobial agents alongside practical diagnostics to combat Antimicrobial Resistance (AMR). Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in July 2022, Boehringer Ingelheim, a Germany-based pharmaceutical company, and Evotec SE, a Germany-based biotechnology company partnered with bioMérieux, a France-based diagnostic solutions provider. The partnership seeks to innovate and produce the succeeding generation of antimicrobials, coupled with effective diagnostics, to address the challenge of Antimicrobial Resistance (AMR). The resultant entity, Aurobac Therapeutics SAS, will leverage the collective strengths of the three founding companies to pioneer a novel precision medicine strategy encompassing the entire continuum from diagnosis to treatment.

Antibiotic Resistance Market Merger And Acquisition: Innoviva Inc. Expands Antibacterial Portfolio With Acquisition Of Entasis Therapeutics Holdings Inc

In July 2022, Innoviva Inc., a US-based pharmaceutical company, acquired Entasis Therapeutics Holdings Inc for an undisclosed amount. Through this acquisition, Innoviva Inc aims to strengthen its portfolio for treating multidrug-resistant gram-negative bacteria and gain a competitive advantage in the market. Entasis Therapeutics Holdings Inc is a US-based company that develops novel antibacterials to treat drug-resistant severe bacterial infections.

Regional Outlook For The Global Antibiotic Resistance Market

North America was the largest region in the antibiotic resistance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotic resistance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibiotic resistance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antibiotic Resistance Market?

The antibiotic resistance market consists of sales of antibiotic drug classes such as carbapenems, glycopeptide antibiotics, penicillin, fluoroquinolones, trimethoprim-sulfamethoxazole, lincosamides, aminoglycosides, polymyxins, and nitroimidazoles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Antibiotic Resistance Industry?

The antibiotic resistance market research report is one of a series of new reports from The Business Research Company that provides antibiotic resistance market statistics, including the antibiotic resistance industry global market size, regional shares, competitors with an antibiotic resistance market share, detailed antibiotic resistance market segments, market trends, and opportunities, and any further data you may need to thrive in the antibiotic resistance industry. This antibiotic resistance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Antibiotic Resistance Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $12.89 billion
Revenue Forecast In 2034 $16.97 billion
Growth Rate CAGR of 7.1% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) By Pathogen: Staphylococcus Aureus, Staphylococcus Pneumonia, Neisseria Gonorrhoeae, Enterococcus Faecium, Escherichia Coli, Klebsiella Pneumonia, Shigella, Clostridium Difficile, Other Pathogens
3) By Disease Type: Urinary Tract Infection, Intra-Abdominal Infection, Blood Stream infections, Clostridium Difficile Infections, Other Disease Types
4) By Mechanism Of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End-users Subsegments: 1) By Beta Lactam Antibiotics: Penicillins, Cephalosporins, Carbapenems, Monobactams
2) By Cephalosporins: First-generation, Second-generation, Third-generation, Fourth-generation
3) By Quinolones Antibiotics: Fluoroquinolones, Other Quinolones
4) By Macrolide Antibiotics: Erythromycin, Azithromycin, Clarithromycin
5) By Tetracyclines: Doxycycline, Minocycline, Tetracycline 6) By Oxazolidinones: Linezolid, Tedizolid 7) By Other Drug Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Merck and Co. Inc., Bristol-Myers Squibb, Sanofi S.A., Thermo Fisher Scientific Inc, AstraZeneca, GlaxoSmithKline Plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Astellas Pharma, Daiichi Sankyo, Chugai Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Bio-Rad Laboratories Inc, Eppendorf Corporation, Takara Bio Inc, Wockhardt Ltd., Paratek Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Theravance Biopharma Inc., Nabriva Therapeutics Plc, Seres Therapeutics Inc, Armata Pharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Antibiotic Resistance Market Characteristics

    3. Antibiotic Resistance Market Trends And Strategies

    4. Antibiotic Resistance Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Antibiotic Resistance Growth Analysis And Strategic Analysis Framework

    5.1. Global Antibiotic Resistance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Antibiotic Resistance Market Growth Rate Analysis

    5.4. Global Antibiotic Resistance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Antibiotic Resistance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Antibiotic Resistance Total Addressable Market (TAM)

    6. Antibiotic Resistance Market Segmentation

    6.1. Global Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Beta Lactum Antibiotic

    Cephalosporins

    Quinolones Antibiotics

    Macrolide Antibiotics

    Tetracyclines

    Oxazolidinones

    Other Drug Classes

    6.2. Global Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Staphylococcus Aureus

    Staphylococcus Pneumonia

    Neisseria Gonorrhoeae

    Enterococcus Faecium

    Escherichia Coli

    Klebsiella Pneumonia

    Shigella

    Clostridium Difficile

    6.3. Global Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Urinary Tract Infection

    Intra-Abdominal Infection

    Blood Stream infections

    Clostridium Difficile Infections

    Other Disease Types

    6.4. Global Antibiotic Resistance Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Protein Synthesis Inhibitors

    Cell Wall Synthesis Inhibitors

    RNA Synthesis Inhibitors

    DNA Synthesis Inhibitors

    Other Mechanism Of Actions

    6.5. Global Antibiotic Resistance Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Homecare

    Specialty Clinics

    Other End-users

    6.6. Global Antibiotic Resistance Market, Sub-Segmentation Of Beta Lactam Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Penicillins

    Cephalosporins

    Carbapenems

    Monobactams

    6.7. Global Antibiotic Resistance Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    First-generation

    Second-generation

    Third-generation

    Fourth-generation

    6.8. Global Antibiotic Resistance Market, Sub-Segmentation Of Quinolones Antibiotics,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Fluoroquinolones

    Other Quinolones

    6.9. Global Antibiotic Resistance Market, Sub-Segmentation Of Macrolide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Erythromycin

    Azithromycin

    Clarithromycin

    6.10. Global Antibiotic Resistance Market, Sub-Segmentation Of Tetracyclines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Doxycycline

    Minocycline

    Tetracycline

    6.11. Global Antibiotic Resistance Market, Sub-Segmentation Of Oxazolidinones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Linezolid

    Tedizolid

    6.12. Global Antibiotic Resistance Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Glycopeptides

    Lipopeptides

    Streptogramins

    Polymyxins

    7. Antibiotic Resistance Market Regional And Country Analysis

    7.1. Global Antibiotic Resistance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Antibiotic Resistance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Antibiotic Resistance Market

    8.1. Asia-Pacific Antibiotic Resistance Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Antibiotic Resistance Market

    9.1. China Antibiotic Resistance Market Overview

    9.2. China Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Antibiotic Resistance Market

    10.1. India Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Antibiotic Resistance Market

    11.1. Japan Antibiotic Resistance Market Overview

    11.2. Japan Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Antibiotic Resistance Market

    12.1. Australia Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Antibiotic Resistance Market

    13.1. Indonesia Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Antibiotic Resistance Market

    14.1. South Korea Antibiotic Resistance Market Overview

    14.2. South Korea Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Antibiotic Resistance Market

    15.1. Western Europe Antibiotic Resistance Market Overview

    15.2. Western Europe Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Antibiotic Resistance Market

    16.1. UK Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Antibiotic Resistance Market

    17.1. Germany Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Antibiotic Resistance Market

    18.1. France Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Antibiotic Resistance Market

    19.1. Italy Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Antibiotic Resistance Market

    20.1. Spain Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Antibiotic Resistance Market

    21.1. Eastern Europe Antibiotic Resistance Market Overview

    21.2. Eastern Europe Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Antibiotic Resistance Market

    22.1. Russia Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Antibiotic Resistance Market

    23.1. North America Antibiotic Resistance Market Overview

    23.2. North America Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Antibiotic Resistance Market

    24.1. USA Antibiotic Resistance Market Overview

    24.2. USA Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Antibiotic Resistance Market

    25.1. Canada Antibiotic Resistance Market Overview

    25.2. Canada Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Antibiotic Resistance Market

    26.1. South America Antibiotic Resistance Market Overview

    26.2. South America Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Antibiotic Resistance Market

    27.1. Brazil Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Antibiotic Resistance Market

    28.1. Middle East Antibiotic Resistance Market Overview

    28.2. Middle East Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Antibiotic Resistance Market

    29.1. Africa Antibiotic Resistance Market Overview

    29.2. Africa Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Antibiotic Resistance Market Competitive Landscape And Company Profiles

    30.1. Antibiotic Resistance Market Competitive Landscape

    30.2. Antibiotic Resistance Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    31. Antibiotic Resistance Market Other Major And Innovative Companies

    31.1. Merck and Co. Inc.

    31.2. Bristol-Myers Squibb

    31.3. Sanofi S.A.

    31.4. Thermo Fisher Scientific Inc

    31.5. AstraZeneca

    31.6. GlaxoSmithKline Plc

    31.7. Eli Lilly and Company

    31.8. Boehringer Ingelheim International GmbH

    31.9. Astellas Pharma

    31.10. Daiichi Sankyo

    31.11. Chugai Pharmaceutical Co. Ltd.

    31.12. Teva Pharmaceutical Industries Ltd.

    31.13. Bio-Rad Laboratories Inc

    31.14. Eppendorf Corporation

    31.15. Takara Bio Inc

    32. Global Antibiotic Resistance Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Antibiotic Resistance Market

    34. Recent Developments In The Antibiotic Resistance Market

    35. Antibiotic Resistance Market High Potential Countries, Segments and Strategies

    35.1 Antibiotic Resistance Market In 2029 - Countries Offering Most New Opportunities

    35.2 Antibiotic Resistance Market In 2029 - Segments Offering Most New Opportunities

    35.3 Antibiotic Resistance Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Antibiotic Resistance Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Antibiotic Resistance Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Antibiotic Resistance Market, Sub-Segmentation Of Beta Lactam Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Antibiotic Resistance Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Antibiotic Resistance Market, Sub-Segmentation Of Quinolones Antibiotics,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Antibiotic Resistance Market, Sub-Segmentation Of Macrolide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Antibiotic Resistance Market, Sub-Segmentation Of Tetracyclines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Antibiotic Resistance Market, Sub-Segmentation Of Oxazolidinones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Antibiotic Resistance Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Antibiotic Resistance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Antibiotic Resistance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Pfizer Inc. Financial Performance
  • Table 84: Johnson and Johnson Financial Performance
  • Table 85: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 86: AbbVie Inc. Financial Performance
  • Table 87: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Antibiotic Resistance Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Antibiotic Resistance Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Antibiotic Resistance Market, Sub-Segmentation Of Beta Lactam Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Antibiotic Resistance Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Antibiotic Resistance Market, Sub-Segmentation Of Quinolones Antibiotics,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Antibiotic Resistance Market, Sub-Segmentation Of Macrolide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Antibiotic Resistance Market, Sub-Segmentation Of Tetracyclines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Antibiotic Resistance Market, Sub-Segmentation Of Oxazolidinones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Antibiotic Resistance Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Antibiotic Resistance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Antibiotic Resistance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Pfizer Inc. Financial Performance
  • Figure 84: Johnson and Johnson Financial Performance
  • Figure 85: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 86: AbbVie Inc. Financial Performance
  • Figure 87: Novartis AG Financial Performance

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the consumer healthcare market research report 2022 with industry size, share, segments and market growth

Read More

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Read More

Global Central Lab Market 2022 – Market Opportunities And Strategies

Read More

What Is The Biohacking Market Overview In 2022?

Read More

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

Read More

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bulk Liquids, Dry Bulk Materials, Forest Products, Refrigerated Goods)

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)

View Report

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact

View Report

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)

View Report

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User (Healthcare Providers, Patients, Payers) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Medical Billing Outsourcing Global Market Report 2025 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Antibiotic Resistance market?

Antimicrobial resistance is a condition that occurs when microorganisms such as bacteria and fungi gain the capacity to resist medications that are meant to kill them. Resistance to infections is challenging to treat, leading to the death of an infected individual in the worst cases. For further insights on the Antibiotic Resistance market, request a sample here

How will the Antibiotic Resistance market drivers and restraints affect the market dynamics? What forces will shape the Antibiotic Resistance industry going forward?

The Antibiotic Resistance market major growth driver - The Impact Of Rising Drug-Resistant Infections On The Antibiotic Resistance Market. For further insights on the Antibiotic Resistance market, request a sample here

What is the forecast market size or the forecast market value of the Antibiotic Resistance market?

The Antibiotic Resistance market size has grown strongly in recent years. The antibiotic resistance market size has grown strongly in recent years. It will grow from $12.21 billion in 2024 to $12.89 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to lack of new antibiotics, misuse and overuse of antimicrobials in humans, animals, and plants, highly contaminated waste effluents, low vaccination rates, lack of diagnostic tools The antibiotic resistance market size is expected to see strong growth in the next few years. It will grow to $16.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to incomplete treatment courses, globalization and travel, poor infection prevention and control, self-medication, cross-species transmission, high population density. Major trends in the forecast period include technological innovations in drug delivery, global collaboration for surveillance, expanding role of artificial intelligence, surge in novel therapies. For further insights on the Antibiotic Resistance market, request a sample here

How is the Antibiotic Resistance market segmented?

The antibiotic resistance market covered in this report is segmented –
1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) By Pathogen: Staphylococcus Aureus, Staphylococcus Pneumonia, Neisseria Gonorrhoeae, Enterococcus Faecium, Escherichia Coli, Klebsiella Pneumonia, Shigella, Clostridium Difficile, Other Pathogens
3) By Disease Type: Urinary Tract Infection, Intra-Abdominal Infection, Blood Stream infections, Clostridium Difficile Infections, Other Disease Types
4) By Mechanism Of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End-users Subsegments:
1) By Beta Lactam Antibiotics: Penicillins, Cephalosporins, Carbapenems, Monobactams
2) By Cephalosporins: First-generation, Second-generation, Third-generation, Fourth-generation
3) By Quinolones Antibiotics: Fluoroquinolones, Other Quinolones
4) By Macrolide Antibiotics: Erythromycin, Azithromycin, Clarithromycin
5) By Tetracyclines: Doxycycline, Minocycline, Tetracycline
6) By Oxazolidinones: Linezolid, Tedizolid
7) By Other Drug Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins For further insights on the Antibiotic Resistance market, request a sample here

Which region has the largest share of the Antibiotic Resistance market? What are the other regions covered in the report?

North America was the largest region in the antibiotic resistance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotic resistance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Antibiotic Resistance market, request a sample here.

Who are the major players in the Antibiotic Resistance market?

Major companies operating in the antibiotic resistance market include Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Merck and Co. Inc., Bristol-Myers Squibb, Sanofi S.A., Thermo Fisher Scientific Inc, AstraZeneca, GlaxoSmithKline Plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Astellas Pharma, Daiichi Sankyo, Chugai Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Bio-Rad Laboratories Inc, Eppendorf Corporation, Takara Bio Inc, Wockhardt Ltd., Paratek Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Theravance Biopharma Inc., Nabriva Therapeutics Plc, Seres Therapeutics Inc, Armata Pharmaceuticals Inc. . For further insights on the Antibiotic Resistance market, request a sample here.

What are the key trends in the Antibiotic Resistance market?

Major trends in the Antibiotic Resistance market include Product Innovations In The Antibiotic Resistance Market. For further insights on the Antibiotic Resistance market, request a sample here.

What are the major opportunities in the Antibiotic Resistance market? What are the strategies for the Antibiotic Resistance market?

For detailed insights on the major opportunities and strategies in the Antibiotic Resistance market, request a sample here.

How does the Antibiotic Resistance market relate to the overall economy and other similar markets?

For detailed insights on Antibiotic Resistance's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Antibiotic Resistance industry?

For detailed insights on the mergers and acquisitions in the Antibiotic Resistance industry, request a sample here.

What are the key dynamics influencing the Antibiotic Resistance market growth? SWOT analysis of the Antibiotic Resistance market.

For detailed insights on the key dynamics influencing the Antibiotic Resistance market growth and SWOT analysis of the Antibiotic Resistance industry, request a sample here.